Intangibles (Narrative) (Details) - USD ($) $ in Thousands |
6 Months Ended | ||
---|---|---|---|
May 13, 2021 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
Finite-Lived Intangible Assets [Line Items] | |||
Purchase of intangible asset | $ 400 | $ 0 | |
Qbrexza [Member] | Journey [Member] | Dermira, Inc. a subsidiary of Eli Lilly [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Percentage of royalty amounts diminution in the event of loss of exclusivity | 50.00% | ||
Purchase of intangible asset | $ 12,500 | ||
Intangible assets, estimated useful lives | 7 years | ||
Payments of milestones | $ 144,000 |
X | ||||||||||
- Definition It represents payments of milestone. No definition available.
|
X | ||||||||||
- Definition Percentage of royalty amounts diminution in the event of loss of exclusivity No definition available.
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|